info icon

Medicines for HER+ breast cancer

RX_ERPLUS

No definition available.

Endpoint definition

FinnGen phenotype data

392423 individuals

diagram downward connector

Apply sex-specific rule None

392423

diagram downward connector

Check conditions None

392423

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Medicine purchases: ATC L02B[AG]

1 out of 7 registries used, show all original rules.

10677

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

10677

diagram downward connector

Include endpoints None

10677

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

10382

diagram downward connector
RX_ERPLUS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze DF9

Summary Statistics

Key figures

All Female Male
?
Number of individuals
10382 10225 157
?
Unadjusted prevalence (%)
2.75 4.85 0.09
?
Mean age at first event (years)
60.49 60.61 52.63

?
Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: RX_ERPLUS – Medicines for HER+ breast cancer
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Medicines for HER+ breast cancer

Endpoint not on priority list, no data to show.